Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235051 · ClinicalTrials.gov registry record · NA
Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors
A NA study of Stage IIIA Breast Cancer and Cancer Survivor, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02235051 is a NA study of Stage IIIA Breast Cancer and Cancer Survivor that has completed, run by City of Hope Medical Center. The registered enrollment target is 50 participants, below the 280-participant average among 29 other Stage IIIA Breast Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02235051, a NA study of Stage IIIA Breast Cancer and Cancer Survivor, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized pilot trial studies how well an exercise intervention works in preventing breast cancer from coming back in postmenopausal breast cancer survivors. Regular exercise may be able to train the body to repair deoxyribonucleic acid (DNA) more efficiently and to respond to inflammation more proficiently, helping to prevent primary and recurrent breast cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- OTHER quality-of-life assessment
- BEHAVIORAL exercise intervention
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-09-07 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235051
The ClinicalTrials.gov registry entry for NCT02235051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 280-participant average among 29 other Stage IIIA Breast Cancer trials with a reported enrollment target (82% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Stage IIIA Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT02235051 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02235051 about?
NCT02235051 is a clinical study titled "Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors". This randomized pilot trial studies how well an exercise intervention works in preventing breast cancer from coming back in postmenopausal breast cancer survivors. Regular exercise may be able to train the body to repair deoxyribonucleic acid (DNA) more efficiently and to respond to inflammation mor...
What is the current status of trial NCT02235051?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-09-07. Estimated completion is 2022-06-03.
What conditions does trial NCT02235051 study?
This clinical trial studies the following conditions: Stage IIIA Breast Cancer, Cancer Survivor, Stage IIA Breast Cancer, Estrogen Receptor-positive Breast Cancer, Stage IIB Breast Cancer.
What interventions are being tested in trial NCT02235051?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), quality-of-life assessment (OTHER), exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02235051?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02235051 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IIIA Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ACTIVE NOT RECRUITING · NA
-
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
COMPLETED · NA
-
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
COMPLETED · NA
-
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer
COMPLETED · NA
-
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
COMPLETED · NA
-
Diindolylmethane in Treating Patients With Breast Cancer
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.